
Mark L. Berch
Examiner (ID: 5655)
| Most Active Art Unit | 1202 |
| Art Unit(s) | 1202, 1614, 1802, 1622, 1611, 1624, 2899 |
| Total Applications | 3573 |
| Issued Applications | 2301 |
| Pending Applications | 170 |
| Abandoned Applications | 1103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6751014
[patent_doc_number] => 20030045535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Bicyclic-substituted 4-amino-pyridopyrimidine derivatives'
[patent_app_type] => new
[patent_app_number] => 10/121831
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15422
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045535.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121831
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121831 | Bicyclic-substituted 4-amino-pyridopyrimidine derivatives | Apr 11, 2002 | Issued |
Array
(
[id] => 7622247
[patent_doc_number] => 06977254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-20
[patent_title] => 'Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/119973
[patent_app_country] => US
[patent_app_date] => 2002-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23496
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/977/06977254.pdf
[firstpage_image] =>[orig_patent_app_number] => 10119973
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/119973 | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists | Apr 9, 2002 | Issued |
Array
(
[id] => 1143119
[patent_doc_number] => 06777549
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-17
[patent_title] => '-lactam production'
[patent_app_type] => B2
[patent_app_number] => 10/119548
[patent_app_country] => US
[patent_app_date] => 2002-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10198
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/777/06777549.pdf
[firstpage_image] =>[orig_patent_app_number] => 10119548
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/119548 | -lactam production | Apr 9, 2002 | Issued |
Array
(
[id] => 6540941
[patent_doc_number] => 20020193587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Penicillin crystal and process for producing the same'
[patent_app_type] => new
[patent_app_number] => 10/089074
[patent_app_country] => US
[patent_app_date] => 2002-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3378
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20020193587.pdf
[firstpage_image] =>[orig_patent_app_number] => 10089074
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/089074 | Penicillin crystal and process for producing the same | Apr 7, 2002 | Abandoned |
Array
(
[id] => 6540953
[patent_doc_number] => 20020193588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Crystals of penicillin and process for the production thereof'
[patent_app_type] => new
[patent_app_number] => 10/089075
[patent_app_country] => US
[patent_app_date] => 2002-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3957
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20020193588.pdf
[firstpage_image] =>[orig_patent_app_number] => 10089075
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/089075 | Crystals of penicillin and process for the production thereof | Apr 7, 2002 | Issued |
Array
(
[id] => 1304592
[patent_doc_number] => 06620930
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-16
[patent_title] => 'Process for preparing 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid'
[patent_app_type] => B1
[patent_app_number] => 10/110162
[patent_app_country] => US
[patent_app_date] => 2002-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2108
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/620/06620930.pdf
[firstpage_image] =>[orig_patent_app_number] => 10110162
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/110162 | Process for preparing 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid | Apr 3, 2002 | Issued |
Array
(
[id] => 6852305
[patent_doc_number] => 20030144508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Process for producing 2,6-dihalogenopurine'
[patent_app_type] => new
[patent_app_number] => 10/296234
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4536
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20030144508.pdf
[firstpage_image] =>[orig_patent_app_number] => 10296234
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/296234 | Process for producing 2,6-dihalogenopurine | Apr 2, 2002 | Issued |
Array
(
[id] => 6537718
[patent_doc_number] => 20020193386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof'
[patent_app_type] => new
[patent_app_number] => 10/109086
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7000
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20020193386.pdf
[firstpage_image] =>[orig_patent_app_number] => 10109086
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/109086 | Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof | Mar 27, 2002 | Abandoned |
Array
(
[id] => 6865615
[patent_doc_number] => 20030191141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof'
[patent_app_type] => new
[patent_app_number] => 10/109513
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6993
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191141.pdf
[firstpage_image] =>[orig_patent_app_number] => 10109513
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/109513 | Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof | Mar 27, 2002 | Abandoned |
Array
(
[id] => 6865614
[patent_doc_number] => 20030191140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof'
[patent_app_type] => new
[patent_app_number] => 10/108729
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6998
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10108729
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/108729 | Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof | Mar 27, 2002 | Abandoned |
Array
(
[id] => 1240013
[patent_doc_number] => 06686343
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-03
[patent_title] => 'Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine A3 receptor affinitive agents'
[patent_app_type] => B1
[patent_app_number] => 10/089244
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10232
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/686/06686343.pdf
[firstpage_image] =>[orig_patent_app_number] => 10089244
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/089244 | Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine A3 receptor affinitive agents | Mar 27, 2002 | Issued |
| 10/089194 | 3-cephem derivatives crystal and method for preparing the same | Mar 26, 2002 | Abandoned |
Array
(
[id] => 6697342
[patent_doc_number] => 20030109536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => '(Oxo-pyrazolo[1,5a]pyrimidin-2-yl) alkyl-carboxamides'
[patent_app_type] => new
[patent_app_number] => 10/107790
[patent_app_country] => US
[patent_app_date] => 2002-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20017
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109536.pdf
[firstpage_image] =>[orig_patent_app_number] => 10107790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/107790 | (Oxo-pyrazolo1,5apyrimidin-2-yl) alkyl-carboxamides | Mar 26, 2002 | Issued |
Array
(
[id] => 6774701
[patent_doc_number] => 20030018039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Cyanamide, alkoxyamino, and urea derivatives of 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones as HIV reverse transcriptase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/108843
[patent_app_country] => US
[patent_app_date] => 2002-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12869
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20030018039.pdf
[firstpage_image] =>[orig_patent_app_number] => 10108843
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/108843 | Cyanamide, alkoxyamino, and urea derivatives of 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones as HIV reverse transcriptase inhibitors | Mar 26, 2002 | Issued |
Array
(
[id] => 1381148
[patent_doc_number] => 06559313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-05-06
[patent_title] => 'Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties'
[patent_app_type] => B2
[patent_app_number] => 10/104133
[patent_app_country] => US
[patent_app_date] => 2002-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19429
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/559/06559313.pdf
[firstpage_image] =>[orig_patent_app_number] => 10104133
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/104133 | Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties | Mar 21, 2002 | Issued |
Array
(
[id] => 6792575
[patent_doc_number] => 20030087919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Rho-kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/103565
[patent_app_country] => US
[patent_app_date] => 2002-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5086
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087919.pdf
[firstpage_image] =>[orig_patent_app_number] => 10103565
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/103565 | Rho-kinase inhibitors | Mar 21, 2002 | Abandoned |
Array
(
[id] => 6761982
[patent_doc_number] => 20030125344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Rho-kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/103566
[patent_app_country] => US
[patent_app_date] => 2002-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16545
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125344.pdf
[firstpage_image] =>[orig_patent_app_number] => 10103566
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/103566 | Rho-kinase inhibitors | Mar 21, 2002 | Abandoned |
Array
(
[id] => 1340966
[patent_doc_number] => 06589950
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-08
[patent_title] => 'Purine derivatives inhibitors of tyrosine protein kinase SYK'
[patent_app_type] => B1
[patent_app_number] => 10/048577
[patent_app_country] => US
[patent_app_date] => 2002-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17357
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 324
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/589/06589950.pdf
[firstpage_image] =>[orig_patent_app_number] => 10048577
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/048577 | Purine derivatives inhibitors of tyrosine protein kinase SYK | Mar 18, 2002 | Issued |
Array
(
[id] => 1282945
[patent_doc_number] => 06642378
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => 'Process for the synthesis of beta-lactam derivatives'
[patent_app_type] => B1
[patent_app_number] => 10/031990
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1366
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642378.pdf
[firstpage_image] =>[orig_patent_app_number] => 10031990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/031990 | Process for the synthesis of beta-lactam derivatives | Mar 12, 2002 | Issued |
Array
(
[id] => 6384296
[patent_doc_number] => 20020179885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Organometallic light-emitting material'
[patent_app_type] => new
[patent_app_number] => 10/094384
[patent_app_country] => US
[patent_app_date] => 2002-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5127
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20020179885.pdf
[firstpage_image] =>[orig_patent_app_number] => 10094384
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/094384 | Organometallic light-emitting material | Mar 7, 2002 | Issued |